Form 8-K - Current report:
SEC Accession No. 0001193125-24-284263
Filing Date
2024-12-23
Accepted
2024-12-23 16:51:31
Documents
15
Period of Report
2024-12-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d666778d8k.htm   iXBRL 8-K 25375
2 EX-5.1 d666778dex51.htm EX-5.1 11879
6 GRAPHIC g666778g1221055905285.jpg GRAPHIC 3608
  Complete submission text file 0001193125-24-284263.txt   172537

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA maia-20241223.xsd EX-101.SCH 2852
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20241223_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20241223_pre.xml EX-101.PRE 11709
17 EXTRACTED XBRL INSTANCE DOCUMENT d666778d8k_htm.xml XML 3744
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 241574537
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)